spacer
home > ebr > summer 2004 > a discussion of the ethical issues which surround pharmacogenetics
PUBLICATIONS
European Biopharmaceutical Review

A Discussion of the Ethical Issues which Surround Pharmacogenetics

People often respond differently to the same medicine. Few medicines are effective for everyone and all may cause adverse reactions or even, occasionally, death. Pharmacogenetics, the study of genetic variation between individuals that affects response to medicines, has the potential to play an important role in improving safety and efficacy. Not only do adverse reactions to medicines have significant costs, in both human and monetary terms, but considerable resources are wasted on prescribing medicines that have little or no effect for particular patients.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Sandy Thomas, Director of the Nuffield Council on Bioethics

Dr Sandy Thomas is Director of the Nuffield Council on Bioethics and Senior Fellow, Science Policy and Technology Research Unit (SPRU) at the University of Sussex. She trained as a Scientist at the University of London (BSc Botany and Zoology, MSc Crop Protection, PhD (Plant Genetics). After lecturing in genetics at the University of London, she became Research Fellow at the Science Policy Research and Technology Unit at the University of Sussex (1987-1997) where she specialised in policy research in life sciences and biotechnology. In 1997, she was appointed as Director of the Nuffield Council on Bioethics through a secondment from the University of Sussex. Over the past decade, she has published widely on the development of public policy for biotechnology, particularly in the area of intellectual property rights and the development and application of genomics. She was a member of the recent UK DFID Commission on Intellectual Property Rights.

spacer
Dr Sandy Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Pharmaceuticals and Healthcare Products

Turkish Cargo

Pharmaceuticals are requiring safe and reliable transportation for being highly temperature sensitive products. Thosepharmaceuticals are; diagnostics, vaccines drugs, sera, plasma, protein clinical trials, biotechnological material, pills and all kind of medicines. Turkish Cargo transports all kind of pharmaceuticals, and has been carrying out its operations of transporting and storing drugs and temperature-sensitive medical supplies successfully and with the experience of 80 years; since 1936.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement